FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:DEPTOR-ENPP2

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: DEPTOR-ENPP2
FusionPDB ID: 22330
FusionGDB2.0 ID: 22330
HgeneTgene
Gene symbol

DEPTOR

ENPP2

Gene ID

64798

5168

Gene nameDEP domain containing MTOR interacting proteinectonucleotide pyrophosphatase/phosphodiesterase 2
SynonymsDEP.6|DEPDC6ATX|ATX-X|AUTOTAXIN|LysoPLD|NPP2|PD-IALPHA|PDNP2
Cytomap

8q24.12

8q24.12

Type of geneprotein-codingprotein-coding
DescriptionDEP domain-containing mTOR-interacting proteinDEP domain containing 6DEP domain-containing protein 6ectonucleotide pyrophosphatase/phosphodiesterase family member 2E-NPP 2autotaxin-textracellular lysophospholipase Dphosphodiesterase I/nucleotide pyrophosphatase 2plasma lysophospholipase D
Modification date2020031320200313
UniProtAcc

Q8TB45

Main function of 5'-partner protein: FUNCTION: Negative regulator of the mTORC1 and mTORC2 signaling pathways. Inhibits the kinase activity of both complexes. {ECO:0000269|PubMed:19446321}.

Q13822

Main function of 5'-partner protein: FUNCTION: Hydrolyzes lysophospholipids to produce the signaling molecule lysophosphatidic acid (LPA) in extracellular fluids (PubMed:15769751, PubMed:26371182, PubMed:27754931, PubMed:14500380, PubMed:12354767,). Major substrate is lysophosphatidylcholine (PubMed:12176993, PubMed:27754931, PubMed:14500380). Also can act on sphingosylphosphorylcholine producing sphingosine-1-phosphate, a modulator of cell motility (PubMed:14500380). Can hydrolyze, in vitro, bis-pNPP, to some extent pNP-TMP, and barely ATP (PubMed:15769751, PubMed:12176993). Involved in several motility-related processes such as angiogenesis and neurite outgrowth. Acts as an angiogenic factor by stimulating migration of smooth muscle cells and microtubule formation (PubMed:11559573). Stimulates migration of melanoma cells, probably via a pertussis toxin-sensitive G protein (PubMed:1733949). May have a role in induction of parturition (PubMed:12176993). Possible involvement in cell proliferation and adipose tissue development (Probable). Tumor cell motility-stimulating factor (PubMed:1733949, PubMed:11559573). Required for LPA production in activated platelets, cleaves the sn-1 lysophospholipids to generate sn-1 lysophosphatidic acids containing predominantly 18:2 and 20:4 fatty acids (PubMed:21393252). Shows a preference for the sn-1 to the sn-2 isomer of 1-O-alkyl-sn-glycero-3-phosphocholine (lyso-PAF) (PubMed:21393252). {ECO:0000269|PubMed:11559573, ECO:0000269|PubMed:12176993, ECO:0000269|PubMed:12354767, ECO:0000269|PubMed:14500380, ECO:0000269|PubMed:15769751, ECO:0000269|PubMed:1733949, ECO:0000269|PubMed:21240271, ECO:0000269|PubMed:21393252, ECO:0000269|PubMed:26371182, ECO:0000269|PubMed:27754931, ECO:0000305|PubMed:15700135}.
Ensembl transtripts involved in fusion geneENST idsENST00000286234, ENST00000523492, 
ENST00000518057, 
ENST00000518109, 
ENST00000075322, ENST00000259486, 
ENST00000427067, ENST00000522167, 
ENST00000522826, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score8 X 8 X 4=25610 X 9 X 6=540
# samples 911
** MAII scorelog2(9/256*10)=-1.50814690367033
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(11/540*10)=-2.29545588352617
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: DEPTOR [Title/Abstract] AND ENPP2 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: DEPTOR [Title/Abstract] AND ENPP2 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)DEPTOR(120977650)-ENPP2(120577195), # samples:3
Anticipated loss of major functional domain due to fusion event.DEPTOR-ENPP2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
DEPTOR-ENPP2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
DEPTOR-ENPP2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
DEPTOR-ENPP2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneENPP2

GO:0009395

phospholipid catabolic process

15280042|26371182

TgeneENPP2

GO:0030149

sphingolipid catabolic process

14500380

TgeneENPP2

GO:0030334

regulation of cell migration

1733949

TgeneENPP2

GO:0034638

phosphatidylcholine catabolic process

21240271

TgeneENPP2

GO:0050731

positive regulation of peptidyl-tyrosine phosphorylation

18054784



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr8:120977650/chr8:120577195)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across DEPTOR (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across ENPP2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000523492DEPTORchr8120977650+ENST00000259486ENPP2chr8120577195-1327431130891253
ENST00000523492DEPTORchr8120977650+ENST00000427067ENPP2chr8120577195-1327431130891253
ENST00000523492DEPTORchr8120977650+ENST00000522167ENPP2chr8120577195-1004431130891253
ENST00000523492DEPTORchr8120977650+ENST00000522826ENPP2chr8120577195-892431130891254
ENST00000523492DEPTORchr8120977650+ENST00000075322ENPP2chr8120577195-892431130891254
ENST00000286234DEPTORchr8120977650+ENST00000259486ENPP2chr8120577195-16307341301194354
ENST00000286234DEPTORchr8120977650+ENST00000427067ENPP2chr8120577195-16307341301194354
ENST00000286234DEPTORchr8120977650+ENST00000522167ENPP2chr8120577195-13077341301194354
ENST00000286234DEPTORchr8120977650+ENST00000522826ENPP2chr8120577195-11957341301194355
ENST00000286234DEPTORchr8120977650+ENST00000075322ENPP2chr8120577195-11957341301194355

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000523492ENST00000259486DEPTORchr8120977650+ENPP2chr8120577195-0.0033726960.9966273
ENST00000523492ENST00000427067DEPTORchr8120977650+ENPP2chr8120577195-0.0033726960.9966273
ENST00000523492ENST00000522167DEPTORchr8120977650+ENPP2chr8120577195-0.0069949930.993005
ENST00000523492ENST00000522826DEPTORchr8120977650+ENPP2chr8120577195-0.0093526640.99064726
ENST00000523492ENST00000075322DEPTORchr8120977650+ENPP2chr8120577195-0.0093526640.99064726
ENST00000286234ENST00000259486DEPTORchr8120977650+ENPP2chr8120577195-0.0014802530.9985197
ENST00000286234ENST00000427067DEPTORchr8120977650+ENPP2chr8120577195-0.0014802530.9985197
ENST00000286234ENST00000522167DEPTORchr8120977650+ENPP2chr8120577195-0.0041862140.9958138
ENST00000286234ENST00000522826DEPTORchr8120977650+ENPP2chr8120577195-0.0072433480.99275666
ENST00000286234ENST00000075322DEPTORchr8120977650+ENPP2chr8120577195-0.0072433480.99275666

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for DEPTOR-ENPP2

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
DEPTORchr8120977650ENPP2chr8120577195431100LCHRLMEHGIIQHGVWNYFQRVLVKK
DEPTORchr8120977650ENPP2chr8120577195734201LCHRLMEHGIIQHGVWNYFQRVLVKK

Top

Potential FusionNeoAntigen Information of DEPTOR-ENPP2 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
DEPTOR-ENPP2_120977650_120577195.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:01IQHGVWNY0.99970.91471018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:25IQHGVWNY0.9930.95651018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:03IQHGVWNY0.9560.85091018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:01IQHGVWNYF0.99880.87261019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B39:06EHGIIQHGV0.99810.955615
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B39:01EHGIIQHGV0.99710.9732615
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B39:24EHGIIQHGV0.99660.8779615
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B38:01EHGIIQHGV0.99570.9908615
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B38:02EHGIIQHGV0.99570.9912615
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:25IQHGVWNYF0.97830.95131019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-A24:25IQHGVWNYF0.96680.5991019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-A24:15IQHGVWNYF0.96470.60391019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-A24:20IQHGVWNYF0.96440.59671019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-A24:31IQHGVWNYF0.95770.58911019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-A31:02HGVWNYFQR0.94220.61181221
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B47:01IQHGVWNYF0.84870.50541019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:03IQHGVWNYF0.82710.78631019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-A24:14IQHGVWNYF0.77370.65151019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:18IQHGVWNYF0.76880.72231019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-A32:13IQHGVWNYF0.76690.98421019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B13:01IQHGVWNYF0.74360.93671019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-A32:13IIQHGVWNY0.32580.9848918
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B52:01IQHGVWNYF0.15910.99331019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:01GIIQHGVWNY0.99880.9558818
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:25GIIQHGVWNY0.99640.9737818
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-A80:01GIIQHGVWNY0.91730.5238818
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B44:03MEHGIIQHGVW0.99990.9901516
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B44:02MEHGIIQHGVW0.99990.8138516
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B44:05MEHGIIQHGVW0.99980.8884516
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:07IQHGVWNY0.9990.60271018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:05IQHGVWNY0.96970.9381018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B39:09EHGIIQHGV0.99720.9354615
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B39:12EHGIIQHGV0.99640.975615
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:07IQHGVWNYF0.99630.59151019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B39:05EHGIIQHGV0.99460.9729615
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:04IQHGVWNYF0.97550.90121019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-A24:02IQHGVWNYF0.96440.59671019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:05IQHGVWNYF0.84260.9161019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:07GIIQHGVWNY0.99670.8909818
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B44:08MEHGIIQHGVW0.99990.8389516
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B44:04MEHGIIQHGVW0.99990.7165516
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:125IQHGVWNY0.99970.91471018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:34IQHGVWNY0.99970.91471018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:27IQHGVWNY0.99970.90441018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:33IQHGVWNY0.99970.91471018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:135IQHGVWNY0.99960.9211018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:50IQHGVWNY0.99960.9421018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:12IQHGVWNY0.99920.95551018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:53IQHGVWNY0.99860.89351018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:35IQHGVWNY0.99840.77491018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:54IQHGVWNY0.99530.87531018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:39IQHGVWNY0.99280.89091018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:68IQHGVWNY0.97810.5051018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:20IQHGVWNY0.96980.96921018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B35:28IQHGVWNY0.96010.97361018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B18:04IQHGVWNY0.93740.95621018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B48:02IQHGVWNY0.75610.96791018
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:135IQHGVWNYF0.99880.91411019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:34IQHGVWNYF0.99880.87261019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:125IQHGVWNYF0.99880.87261019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:33IQHGVWNYF0.99880.87261019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:27IQHGVWNYF0.99870.91571019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:24IQHGVWNYF0.99830.92561019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:50IQHGVWNYF0.99820.94071019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:35IQHGVWNYF0.9970.76991019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B39:31EHGIIQHGV0.99680.9739615
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B38:05EHGIIQHGV0.99570.9908615
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:12IQHGVWNYF0.98840.96281019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:39IQHGVWNYF0.98070.8861019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:53IQHGVWNYF0.97220.83581019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:13IQHGVWNYF0.93710.79471019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:73IQHGVWNYF0.92080.79191019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-A32:01IQHGVWNYF0.91480.94271019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:30IQHGVWNYF0.89660.8071019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:54IQHGVWNYF0.85270.78161019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:20IQHGVWNYF0.84170.95551019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B35:20IQHGVWNYF0.81280.9591019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B35:28IQHGVWNYF0.80230.96161019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B39:11EHGIIQHGV0.76080.8772615
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B18:04IQHGVWNYF0.75790.94351019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B48:02IQHGVWNYF0.67470.94811019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-C02:10IQHGVWNYF0.49160.95891019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-C02:02IQHGVWNYF0.49160.95891019
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:125GIIQHGVWNY0.99880.9558818
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:33GIIQHGVWNY0.99880.9558818
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:27GIIQHGVWNY0.99880.9644818
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:34GIIQHGVWNY0.99880.9558818
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:135GIIQHGVWNY0.99850.962818
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:50GIIQHGVWNY0.99850.9578818
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:39GIIQHGVWNY0.99650.9423818
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B15:35GIIQHGVWNY0.9960.9638818
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B44:22MEHGIIQHGVW0.99990.8138516
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B44:26MEHGIIQHGVW0.99990.9901516
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B44:13MEHGIIQHGVW0.99990.9901516
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B44:07MEHGIIQHGVW0.99990.9901516
DEPTOR-ENPP2chr8120977650chr8120577195734HLA-B44:21MEHGIIQHGVW0.99980.6728516

Top

Potential FusionNeoAntigen Information of DEPTOR-ENPP2 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Fusion breakpoint peptide structures of DEPTOR-ENPP2

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
1779EHGIIQHGVWNYFQDEPTORENPP2chr8120977650chr8120577195734

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of DEPTOR-ENPP2

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN1779EHGIIQHGVWNYFQ-7.29174-7.40514
HLA-B14:023BVN1779EHGIIQHGVWNYFQ-4.74919-5.78449
HLA-B52:013W391779EHGIIQHGVWNYFQ-5.07451-5.18791
HLA-B52:013W391779EHGIIQHGVWNYFQ-2.86294-3.89824
HLA-A11:014UQ21779EHGIIQHGVWNYFQ-4.62205-5.65735
HLA-A24:025HGA1779EHGIIQHGVWNYFQ-11.701-11.8144
HLA-A24:025HGA1779EHGIIQHGVWNYFQ-4.6967-5.732
HLA-B44:053DX81779EHGIIQHGVWNYFQ-5.76162-5.87502
HLA-B44:053DX81779EHGIIQHGVWNYFQ-3.98447-5.01977
HLA-A02:016TDR1779EHGIIQHGVWNYFQ-2.29826-3.33356

Top

Vaccine Design for the FusionNeoAntigens of DEPTOR-ENPP2

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
DEPTOR-ENPP2chr8120977650chr81205771951018IQHGVWNYTCCAGCATGGGGTCTGGAATTATT
DEPTOR-ENPP2chr8120977650chr81205771951019IQHGVWNYFTCCAGCATGGGGTCTGGAATTATTTCC
DEPTOR-ENPP2chr8120977650chr81205771951221HGVWNYFQRATGGGGTCTGGAATTATTTCCAAAGGG
DEPTOR-ENPP2chr8120977650chr8120577195516MEHGIIQHGVWTGGAGCATGGCATCATCCAGCATGGGGTCTGGA
DEPTOR-ENPP2chr8120977650chr8120577195615EHGIIQHGVAGCATGGCATCATCCAGCATGGGGTCT
DEPTOR-ENPP2chr8120977650chr8120577195818GIIQHGVWNYGCATCATCCAGCATGGGGTCTGGAATTATT
DEPTOR-ENPP2chr8120977650chr8120577195918IIQHGVWNYTCATCCAGCATGGGGTCTGGAATTATT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence

Top

Information of the samples that have these potential fusion neoantigens of DEPTOR-ENPP2

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
BRCADEPTOR-ENPP2chr8120977650ENST00000286234chr8120577195ENST00000075322TCGA-E9-A1RH-01A

Top

Potential target of CAR-T therapy development for DEPTOR-ENPP2

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to DEPTOR-ENPP2

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to DEPTOR-ENPP2

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource